2 published verifications about Breast Cancer Breast Cancer ×
“As of April 2026, the World Health Organization has classified oral contraceptives (birth control pills) as Group 1 carcinogens, indicating sufficient evidence of a link to cancer, particularly breast and cervical cancers.”
The claim contains a factual core but overgeneralizes and misattributes in ways that materially distort the picture. IARC — the WHO's cancer research agency, not the WHO itself — classified specifically combined estrogen-progestogen oral contraceptives as Group 1 carcinogens, not all "birth control pills." Progestogen-only pills carry a different, lower classification. The claim also omits that these same pills have well-documented protective effects against ovarian and endometrial cancers, presenting a one-sided risk profile.
“An artificial intelligence model can detect early-stage breast cancer with approximately 94% accuracy, surpassing the average performance of radiologists.”
The claim conflates AUC/AUROC scores (~0.93) with "accuracy," which are different metrics. The best available meta-analytic evidence reports pooled AI sensitivity of 0.85 and AUC of 0.89 — not 94%. Critically, 2025 RSNA studies show AI misses approximately 14% of cancers, with false negatives concentrated in smaller, early-stage tumors in dense breasts — the very cases the claim highlights. While AI can match or modestly exceed average radiologists in some contexts, the specific "~94% accuracy for early-stage detection" framing significantly overstates the evidence.